{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dementia/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"4c0fe55f-40c9-5a1c-8cf3-1ec8d88406d5","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 86688216-80a7-4d7c-9fd1-b07df17ae7ca --><h2>How should I assess a person with suspected dementia?</h2><!-- end field 86688216-80a7-4d7c-9fd1-b07df17ae7ca -->","summary":"","htmlStringContent":"<!-- begin item 218afcf9-4d03-42ba-a285-83deaa6e07e9 --><!-- begin field 6f8fbae6-e6a2-46af-b9a0-0ba7214ee21a --><p><strong>To assess a person with suspected dementia:</strong></p><ul><li><strong>Take a history from the person (and, if possible, a close informant) asking about:</strong><ul><li>Concerns, <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/clinical-features/\">cognitive symptoms</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/clinical-features/\">behavioural and psychological symptoms of dementia</a> (BPSD) and impact on activities of daily life (ADLs) — the timescale of onset and deterioration can help differentiate dementia from <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/differential-diagnosis/\">other conditions</a> with similar features such as delirium, depression, and thyroid disorders.</li><li>Comorbidities such as stroke, depression, or epilepsy to ensure alternative causes of symptoms are identified and management of co-morbidities is optimized.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/dementia/background-information/risk-factors/\">Risk factors</a> for dementia such as cardiovascular risk factors, family history of genetic causes of dementia, learning difficulties and neurological conditions such as stroke and Parkinson's disease.</li><li>Drugs — review medication (including over-the-counter and alternative medication) to identify drugs, which may affect cognition such as benzodiazepines, anticholinergic drugs and analgesics.</li></ul></li><li><strong>Discuss the possibility of dementia:</strong><ul><li>Explain why a more detailed assessment is advisable, seek <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/assessment/#consent-capacity\">informed consent</a>, and ask the person if they would like to know the diagnosis and who else they would like involved and informed. </li><li>If person lacks <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/assessment/#consent-capacity\">mental capacity</a> to give consent or decide who should or should not be involved, act in their best interests in accordance with the <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/assessment/#mental-capacity-act-2005\">Mental Capacity Act (2005)</a>. <ul><li>An <a href=\"http://www.bma.org.uk/advice/employment/ethics/mental-capacity/mental-capacity-toolkit\" data-hyperlink-id=\"02ea92bc-d81a-4c09-8b90-a8f70159a308\">online toolkit</a> to help assess capacity is available from the British Medical Association (BMA) website (<a href=\"http://www.bma.org.uk/\" target=\"\" data-hyperlink-id=\"bbaaccaa-6bcc-4c5b-bcfc-a8f70159a3f8\">www.bma.org.uk</a>).</li></ul></li></ul></li><li><strong>Assess cognition:</strong><ul><li>Use a standardized <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/assessment/#cognitive-assessment-tools\">cognitive assessment tool</a> such as the 10-point cognitive screener (10-CS), the 6-item cognitive impairment test (6CIT), the 6-item screener, the Memory Impairment Screen (MIS), the Mini-Cog, or Test Your Memory (TYM). <ul><li>Take into account factors known to affect performance (such as educational level, prior level of functioning, language, sensory impairment, and physical or mental health problems) when interpreting scores.</li><li>Cognition in people with learning disabilities, should be assessed by an intellectual disability specialist using a modified cognitive screening tool.</li></ul></li><li>A guide to the assessment of cognition '<a href=\"https://www.alzheimers.org.uk/downloads/download/1045/helping_you_to_assess_cognition_a_practical_toolkit_for_clinicians\" data-hyperlink-id=\"b3596ecb-8274-4c1e-b8b2-a8f70159a524\">Assessing cognition in older people: a practical toolkit for health professionals</a>' is available on the Alzheimer's society website (<a href=\"https://www.alzheimers.org.uk/\" data-hyperlink-id=\"5d305e69-afc3-4c62-82d4-a8f70159a59d\">www.alzheimers.org.uk</a>).</li></ul></li><li><strong>Assess daily functioning by asking about:</strong><ul><li>Activities of daily living such as personal care (including bathing, dressing, and continence), doing housework, preparing meals, shopping, managing finances, and taking drug treatments as prescribed.</li><li>Safety in the home and outside.</li><li>Social functioning and support.</li><li>Driving — for more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/management/suspected-dementia/#driving\">Driving</a>.</li></ul></li><li><strong>Assess for <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/clinical-features/\">behavioural and psychological symptoms of dementia</a> (BPSD)</strong> <strong>asking about factors which may trigger or exacerbate BPSD, including:</strong><ul><li>Co-morbidities and acute illnesses — pain or conditions such as urinary tract infection, constipation, dehydration, anaemia, and delirium can contribute to the development of BPSD.</li><li>Underlying psychiatric illness (such as depression).</li><li>Sensory deficits such as visual impairment or hearing loss.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/differential-diagnosis/\">Adverse drug effects</a>.</li><li>Inability of the person to communicate verbally — may lead to attempts to communicate needs in other ways that can be seen as BSPD.</li></ul><ul><li>Emotional upset of the carer (such as stress or depression).</li><li>Communication difficulties between the carer and the person — may lead to anger or shouting.</li><li>Environmental issues such as clutter, changes to the environment, over or under stimulation (lack of anything interesting to look at, excess noise and/or people), and lack of an established routine.</li></ul></li><li><strong>Examine the person looking for:</strong><ul><li>Focal neurological signs (such as hemiparesis or visual field defects).</li><li>Gait and balance disturbance.</li><li>Cardiovascular signs, such as hypertension and arrhythmias.</li><li>Weight loss — ensure a recent weight is recorded.</li><li>Other potential causes of symptoms, such as visual or auditory problems, and acute physical or mental illness.</li></ul></li><li><strong>To help identify reversible causes of dementia and exclude other causes of symptoms arrange appropriate investigations </strong><strong>including:</strong><ul><li><strong>In most cases:</strong><ul><li>Full blood count.</li><li>Erythrocyte sedimentation rate (ESR).</li><li>Urea and electrolytes.</li><li>Calcium.</li><li>HbA1c.</li><li>Liver function tests.</li><li>Thyroid function tests.</li><li>Serum B12 and folate levels.</li></ul></li><li><strong>If clinically indicated:</strong><ul><li>A midstream urine, for example when delirium is a possibility.</li><li>Chest X-ray, electrocardiogram (ECG), syphilis serology, and HIV testing.</li></ul></li></ul></li></ul><!-- end field 6f8fbae6-e6a2-46af-b9a0-0ba7214ee21a --><!-- end item 218afcf9-4d03-42ba-a285-83deaa6e07e9 -->","topic":{"id":"de9cbb4d-2d69-500f-be27-dc83f76dc3ba","topicId":"2491e3e7-cc21-42b9-8972-e54804b4782f","topicName":"Dementia","slug":"dementia","lastRevised":"Last revised in October 2020","chapters":[{"id":"af834011-0042-530a-8f9a-acd5828e0a34","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a0360b83-4555-5079-897f-12b2d555c1af","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"52cd8e36-39cd-5259-8819-bd96087b0265","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"60bd6b27-027f-56a6-a018-a1d694a6a2f3","slug":"changes","fullItemName":"Changes"},{"id":"7ced1224-30c2-5f30-9caf-3764f3665ae4","slug":"update","fullItemName":"Update"}]},{"id":"fae05cff-ad98-52fa-89b4-b97369195d59","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2f3b4bd3-e7cf-5492-afe0-0a5b230eab7e","slug":"goals","fullItemName":"Goals"},{"id":"9104785e-e491-5ca3-b3d3-7e951385bce9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a9c56eb4-bc0e-51cc-b486-a54c23906bc0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebf62eba-a4cd-536c-8c9f-c9505b0e7482","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a71b8dc2-79f8-5d24-b668-c792abc5a624","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c87232ba-6926-5ff2-98d2-f8839b0c0d37","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"825c29c3-9d55-54ae-b54d-8ee2ac796e97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"46c6316f-eec0-580a-80ec-2112d2f0122f","slug":"definition","fullItemName":"Definition"},{"id":"f485482d-0d4e-52cb-9df4-3548bc72a566","slug":"causes","fullItemName":"Causes"},{"id":"87101d89-6073-57cc-b247-48be586ef185","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"58f6ec5a-c90b-5e64-a476-fc9fca39c6ae","slug":"prevalence","fullItemName":"Prevalence"},{"id":"994469e3-f824-5f48-b755-7f74dd360680","slug":"prognosis","fullItemName":"Prognosis"},{"id":"718f9ed4-d725-5f6e-a86f-5df88719cd52","slug":"complications","fullItemName":"Complications"}]},{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"565bac2a-ada3-5b0a-ab7d-6681501b2c4a","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"4c0fe55f-40c9-5a1c-8cf3-1ec8d88406d5","slug":"assessment","fullItemName":"Assessment"},{"id":"ef7780bd-8e94-5f95-870f-92ab930c4365","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3069f5e5-519f-50ec-81b7-c8948a5b3117","fullItemName":"Management","slug":"management","subChapters":[{"id":"c6c0cbc2-18fc-5bf8-973d-bc38b9001f28","slug":"suspected-dementia","fullItemName":"Scenario: Suspected dementia"},{"id":"6320a2da-e9d6-5f57-94d9-0433261edf89","slug":"follow-up-of-confirmed-dementia-in-primary-care","fullItemName":"Scenario: Follow up of confirmed dementia in primary care"},{"id":"343a59fa-439e-5ab9-9d3b-28a893d55d2f","slug":"management-of-end-stage-dementia","fullItemName":"Scenario: Management of end-stage dementia"}]},{"id":"9a2639de-07aa-5fe3-8f09-5c005f9c29dd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"58ed8441-e3ca-566e-9afb-92a5ba60b1dd","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"67092bd7-2ab4-5e8b-8ead-5301454da4a8","slug":"acetylcholinesterase-inhibitors","fullItemName":"Acetylcholinesterase inhibitors"},{"id":"f4ced652-a6de-5e19-ae37-6de43dfd8104","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"45d5f01b-c1c2-53dc-91b4-8f7a90983fd5","slug":"memantine-hydrochloride","fullItemName":"Memantine hydrochloride"}]},{"id":"1e87c908-2ab5-5cba-8d6a-958c03f7a6cd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fc7a2bcf-854b-5ca4-9b02-2dcaaebe1162","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7bcb26a3-cc69-5201-9fd9-6353e27b412f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c383917-58d0-5036-8217-5d9fd81cb2cb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fdb8af52-aeee-52bd-be79-c5534939d42f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a9f930f3-f8b6-5c8f-b8ca-b3155e0c23d3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"668c11fa-1873-58d4-b0e2-3eab90e8fbff","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"67c4aef9-fbf4-5bf6-8dc5-c501f74b1fe3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"15aa2337-adac-52f4-a888-b0a117cd4775","slug":"consent-capacity","fullItemName":"Consent and capacity","depth":3,"htmlHeader":"<!-- begin field b9fcfa6c-a040-44c1-b2d9-3377da049996 --><h3>What should I know about consent and mental capacity?</h3><!-- end field b9fcfa6c-a040-44c1-b2d9-3377da049996 -->","summary":null,"htmlStringContent":"<!-- begin item e4e4f95c-4f4f-46d2-97c7-bee5371854a9 --><!-- begin field 12c5f251-2edc-4697-a465-e47912754c2f --><h4>Consent</h4><ul><li>Explicit or implied patient consent is needed for all examinations, treatments, or interventions, with the exceptions of emergency treatment or when prescribed by law (for example compulsory treatment under mental health legislation).<ul><li>Explicit or express consent is when a person actively agrees verbally or in writing.</li><li>Implied consent is signalled by the behaviour of a person who is aware of and understands, the proposed course of action.</li></ul></li><li>Consent is not a one-off event — ongoing discussion is needed as treatment evolves.</li></ul><h4>Mental capacity</h4><ul><li>In order to consent, a person must have the proposed action explained to them and have the mental capacity to make an informed decision.</li><li>Mental capacity must be assessed for each decision at the time it is made — capacity should be re-assessed if the person's condition changes.</li><li>To establish that a person lacks mental capacity to make a specific decision:<ul><li>They must have ‘an impairment of, or a disturbance in the functioning of, the mind or brain’ which may affect their ability to make a specific decision <em>and</em></li><li>Because of this be unable to:<ul><li>Understand the relevant information and the consequences of deciding against a treatment or intervention <em>and,</em></li><li>Retain the information long enough to consider it and come to a decision <em>and,</em></li><li>Make the decision without pressure from anyone else <em>and,</em></li><li>Communicate the decision (by any means).</li></ul></li></ul></li><li>If a person lacks the capacity to make a decision, the provisions of the <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/diagnosis/assessment/#mental-capacity-act-2005\">Mental Capacity Act, 2005</a> and its code of practice should be followed.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]</p><!-- end field 12c5f251-2edc-4697-a465-e47912754c2f --><!-- end item e4e4f95c-4f4f-46d2-97c7-bee5371854a9 -->","subChapters":[]},{"id":"dbd84dd8-3880-58ef-9255-da086f72f3c8","slug":"mental-capacity-act-2005","fullItemName":"Mental Capacity Act (2005)","depth":3,"htmlHeader":"<!-- begin field 283401bc-9542-4c28-9f1d-5bda8ead75c9 --><h3>Legal framework for decisions related to mental capacity</h3><!-- end field 283401bc-9542-4c28-9f1d-5bda8ead75c9 -->","summary":null,"htmlStringContent":"<!-- begin item 95eae7b6-d838-4831-9a7d-752463a08cb6 --><!-- begin field bc71cffc-f5cf-4efb-b7e4-0779f79a5870 --><ul><li><strong>The legal framework for decisions on mental capacity is governed by</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Department for Constitutional Affairs, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]<strong>:</strong><ul><li>The Mental Capacity Act 2005 in England and Wales.</li><li>The Adults with Incapacity (Scotland) Act 2000 in Scotland.</li><li>Common law in Northern Ireland.</li></ul></li><li><strong>The Mental Capacity Act (MCA) 2005 has five key principles</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Department of Health, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">SCIE, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]<strong>:</strong><ul><li>Assume capacity — a person must be assumed to have capacity until proven otherwise.</li><li>Maximize decision-making capacity — all practical support (such as extra time for assessment, repeating the assessment if capacity fluctuates, or using an interpreter, sign language, or pictures) to help a person make a decision should be given before deciding that a person lacks capacity.</li><li>Freedom to make seemingly unwise decisions — an apparently unwise decision in itself does not prove incapacity. </li><li>Best interests — all decisions or actions taken on behalf of the person (taking into account their wishes, advance decisions, beliefs, and values) must be in their best interests.</li><li>Least restrictive option — when making a decision on another person's behalf, the alternative that achieves the necessary goal and interferes the least with the person's rights and freedom of action must be chosen.</li><li>Further information is available in the '<a href=\"http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/497253/Mental-capacity-act-code-of-practice.pdf\" data-hyperlink-id=\"bb2beaf3-d221-4a0c-a155-a8f7014c0fea\">Mental Capacity Act 2005 Code of Practice</a>' available on the GOV.UK website (<a href=\"https://www.gov.uk/\" data-hyperlink-id=\"f6409151-6372-474c-9e60-a8f7014c1014\">w</a><a href=\"https://www.gov.uk/\" data-hyperlink-id=\"cdc9e145-ac47-4653-8aff-a8f7014c1014\">ww.gov.uk</a>).</li></ul></li><li><strong>Deprivation of liberty</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">SCIE, 2015</a>]<ul><li>A deprivation of liberty occurs when a person does not consent to care or treatment, for example, a person with dementia who is not free to leave a care home and lacks capacity to consent to this.</li><li>Deprivation of Liberty Safeguards (DoLS) are an amendment to the Mental Capacity Act (2005) to ensure that any care restricting a person's liberty is appropriate and in their best interests. <ul><li>Deprivation of liberty for care provision is only lawful if it has been authorized in accordance with the DoLS.</li></ul></li><li>Further information on DoLS is available on the Social Care Institute for Excellence website (<a href=\"http://www.scie.org.uk/\" data-hyperlink-id=\"854d6f23-0471-498d-93f8-a8f7014c1014\">www.scie.org.uk</a>).</li></ul></li><li><strong>Lasting power of attorney (LPA) </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Department for Constitutional Affairs, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]<ul><li>LPA is a document in which a person can nominate someone else to make certain decisions on their behalf (for example on finances, health, and personal welfare) when they are unable to do so themselves.</li><li>The Mental Capacity Act 2005 provides the legal framework to give a named person authority to make these decisions on another person's behalf. LPA replaces what was previously known as 'enduring power of attorney'. </li><li>To be valid, LPA documents must be registered with the Office of the Public Guardian. If there are concerns relating to decisions taken under the authority of a LPA, the case can be referred to the Court of Protection.</li><li>Further information on LPA is available on the GOV.UK website (<a href=\"http://www.gov.uk/\" data-hyperlink-id=\"a6324a71-d6a3-4d50-9a6c-a8f7014c107b\">www.gov.uk</a>).</li></ul></li><li><strong>Court of Protection </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">HM Government, 2015</a>]<ul><li>The Court of Protection makes decisions on financial and welfare issues for people who lack mental capacity. It is responsible for:<ul><li>Deciding if a person has the capacity to make a particular decision for themselves.</li><li>Appointing deputies to make decisions for people lacking capacity.</li><li>Giving permission to make one-off decisions on behalf of a person without capacity.</li><li>Dealing with urgent applications where a decision must be made on behalf of another without delay.</li><li>Making decisions on LPA (or enduring power of attorney made and signed before October 1, 2007) and considering objections to these.</li><li>Consideration of applications to make statutory wills or gifts.</li><li>Making decisions about when someone can be deprived of their liberty under the Mental Capacity Act (2005).</li></ul></li></ul></li><li><strong>Advance decisions (sometimes known as a 'living will') </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Department for Constitutional Affairs, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]<strong>:</strong><ul><li>Advance decisions allow people who understand the implications of their choices to state their treatment wishes in advance. They can be used to:<ul><li>Authorize or request specific procedures.</li><li>Refuse treatment in a predefined future situation (also called an advance directive).</li></ul></li><li>Advance refusals of treatment are legally binding (under common law) if:<ul><li>The person is an adult, <em>and</em></li><li>Was competent and fully informed when making the decision, <em>and</em></li><li>The decision is clearly applicable to the current circumstances, <em>and</em></li><li>There is no reason to believe that they have since changed their mind.</li></ul></li><li>Advance requests for treatment do not have the same binding status but should be considered when assessing best interests.<ul><li>There is a duty to take reasonable steps (such as artificial nutrition and hydration) to keep the person alive if that is the patient’s known wish.</li></ul></li></ul></li><li><strong>Independent mental capacity advocate (IMCA) </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Department for Constitutional Affairs, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">SCIE, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016b</a>]<ul><li>IMCAs are commissioned from independent organizations by the NHS and local authorities to ensure that the MCA (2005) is being followed.</li><li>The role of an IMCA is to support and represent people who lack capacity and who do not have anyone else to represent them in decisions about changes in long-term accommodation or serious medical treatment. An IMCA may also be provided for decisions about care reviews or adult protection.</li><li>Further information on IMCA, including how to find an IMCA, is available on the Social Care Institute for Excellence website (<a href=\"http://www.scie.org.uk/publications/imca/\" data-hyperlink-id=\"b4839c5c-004a-4d3a-b84c-a8f7014c107b\">www.scie.org.uk/publications/imca/</a>).</li></ul></li></ul><!-- end field bc71cffc-f5cf-4efb-b7e4-0779f79a5870 --><!-- end item 95eae7b6-d838-4831-9a7d-752463a08cb6 -->","subChapters":[]},{"id":"3deafb2c-0fa2-5af9-a155-b18d10d2437e","slug":"cognitive-assessment-tools","fullItemName":"Cognitive assessment tools","depth":3,"htmlHeader":"<!-- begin field 742add0c-6da3-4382-96a0-1e1386699d3e --><h3>Cognitive assessment tools</h3><!-- end field 742add0c-6da3-4382-96a0-1e1386699d3e -->","summary":null,"htmlStringContent":"<!-- begin item caafd7e2-6df7-43aa-8e3d-774926ac1c34 --><!-- begin field a9581265-0021-4d54-936f-e21f39904ad2 --><p><strong>Many different cognitive assessment tools are available — those suggested by NICE include:</strong></p><ul><li><strong>10-point Cognitive Screener (10-CS)</strong><ul><li>The 10-CS involves 3 temporal orientation questions (year, month, date), a 3 word recall and a 4 point scaled animal naming task. </li><li>One point is scored for each of the temporal questions and each word recalled, and the scores for the animal naming task range from 0 points for 0 to 5 animals, to 4 points for 15 or more animals.</li><li>A score of 8 or more is normal, 6-7 indicates possible cognitive impairment, and 0-5 indicates probable cognitive impairment. </li></ul></li><li><strong>6-item Cognitive Impairment Test (6CIT)</strong><ul><li>The 6-CIT consists of 6 questions including orientation, learning an address, counting backwards from 20, and stating the months of the year in reverse.</li><li>A computerized version of the 6-CIT with automated scoring is available on some general practice computer systems.</li><li>The 6-CIT is available in the Alzheimer's Society <a href=\"https://www.alz.org/media/documents/cognitive-assessment-toolkit.pdf\" data-hyperlink-id=\"d5bada12-a1eb-493c-9637-abdc00a2d7d8\">Cognitive Assessment Toolkit</a>.</li></ul></li><li><strong>6-item Screener</strong><ul><li>The 6-item Screener consists of 3 questions (year, month, day of the week) and a 3 word recall.  </li><li>Two or more errors are considered high risk for cognitive impairment.</li></ul></li><li><strong>Memory Impairment Screener (MIS)</strong><ul><li>The MIS involves showing the person 4 words at the start of the assessment. The person is then given a category and asked to identify which word fits into that category. This is completed for all 4 words and it is explained that they will be asked to remember the words in a few minutes. A distractor activity is performed for 2 or 3 minutes (for example, counting to 20 and back, counting back from 100 by 7, spelling the word 'world' backwards) and then the person is asked to recall the 4 words.</li><li>The maximum score is 8 (2 points for each word recalled without prompting and 1 point for each word that requires prompting). A score of 5–8 indicates no cognitive impairment, and a score of 4 or less indicates possible cognitive impairment.  </li><li>The MIS is available in the Alzheimer's Society <a href=\"https://www.alz.org/media/documents/cognitive-assessment-toolkit.pdf\" data-hyperlink-id=\"bc84d684-f4fd-4359-a4dd-abdc00a2d806\">Cognitive Assessment Toolkit</a>.</li></ul></li><li><strong>Mini-Cog</strong><ul><li>The <a href=\"https://mini-cog.com/\" data-hyperlink-id=\"55e6bef1-d20d-48a5-97e9-abdc00a2d82c\">Mini-Cog</a> consists of two components: a 3-item recall test for memory and a clock drawing test. </li><li>There is one point for each word remembered after the clock has been drawn, and 2 points for a normal clock. A score of less than 3 has been validated for dementia screening. </li></ul></li><li><strong>Test Your Memory (TYM)</strong><ul><li>The <a href=\"http://www.tymtest.com/\" data-hyperlink-id=\"470f97ff-556c-4b51-8545-abdc00a2d8e2\">TYM</a> is a self-administered test, which is a series of 10 tasks: orientation (10 points), ability to copy a sentence (2 points), semantic knowledge (3 points), calculation (4 points), verbal fluency (4 points), similarities (4 points), naming (5 points), visuospatial abilities (2 tasks, total 7 points), and recall of a copied sentence (6 points). The ability to do the test is also scored (5 points).</li><li>The maximum score is 50 points. A score of 42 or less detects 95% of cases of mild Alzheimer's with a specificity of 86%, and a score of 44 or less detects 96% of people with mild Alzheimer's.</li></ul></li><li>Other assessment tools such as the Abbreviated mental test score (AMTS), Dementia commissioning for quality and innovation (CQUIN), Addenbrooke's cognitive examination-III (ACE-III), and the Montreal cognitive assessment (MoCA) are available in the Alzheimer's Society toolkit '<em><a href=\"https://www.alzheimers.org.uk/downloads/download/1045/helping_you_to_assess_cognition_a_practical_toolkit_for_clinicians\" data-hyperlink-id=\"5ce2a81b-36d7-4908-94ba-a8f7014cb138\">Helping you to assess cognition: A practical toolkit</a></em>'. </li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Brown, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Young, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Apolinario, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2018a</a>] </p><!-- end field a9581265-0021-4d54-936f-e21f39904ad2 --><!-- end item caafd7e2-6df7-43aa-8e3d-774926ac1c34 -->","subChapters":[]},{"id":"fa5fa89a-7ee1-55de-b343-ab6554af43a5","slug":"basis-for-recommendation-ceb","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field e9a38368-5cee-4f71-9a70-4b86b2d38dd5 --><h3>Basis for recommendation</h3><!-- end field e9a38368-5cee-4f71-9a70-4b86b2d38dd5 -->","summary":null,"htmlStringContent":"<!-- begin item ceb4cf57-77ca-4908-9006-1a08701f064e --><!-- begin field febd25f4-cc52-4731-b9ca-4501d14afe45 --><p>The recommendations on how to assess a person with suspected dementia are based largely on the National Institute for Health and Care Excellence (NICE) guideline <em>Dementia: supporting people with dementia and their carers in health and social care (CG42)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>], the European Federation of Neurological Societies (EFNS-ENS)<em> Guidelines on the diagnosis and management of disorders associated with dementia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>], the Guidelines and Protocols Advisory Committee (GPAC) guideline <em>Cognitive impairment: recognition, diagnosis and management in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">GPAC, 2014</a>], and the British Psychological Society guideline <em>Dementia and People with Intellectual Disabilities Guidance on the assessment, diagnosis, interventions and support of people with intellectual disabilities who develop dementia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">British Psychological Society, 2015</a>], the NICE pathway on dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE Pathway, 2016</a>], the Royal College of General Practitioners<em> Policy Position Statement on the role of general practice in the identification and treatment of people with dementia</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">RCGP, 2013</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Iliffe, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Villars, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Cameron, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Young, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMJ Best Practice, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Kales, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</p><h4>Early identification</h4><ul><li>Expert opinion in a guideline and review article on dementia is that early diagnosis is needed to allow treatment of reversible causes of dementia, enable the person with dementia to make diagnostic and treatment decisions while they still have capacity, and help people with dementia and their family/carers to prepare for future problems and to contribute to the care plan [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Moyer, 2014</a>].</li></ul><h4>Taking a collateral history</h4><ul><li>Expert opinion in guidelines and review articles on dementia is that:<ul><li>A person with dementia may deny, or compensate for, cognitive changes and functional ability, especially in early dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">GPAC, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</li><li>Family concern is of particular importance in identifying dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</li><li>Behavioural and Psychological Symptoms of Dementia (BPSD) are most often reported by the carer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Young, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>].</li></ul></li></ul><h4>Assessing for comorbidities and alternative causes of symptoms</h4><ul><li>Almost one-fifth of people with dementia have other serious conditions such as stroke, diabetes, or visual impairment — appropriate management of co-morbidities can improve functional ability in people with dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Villars, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Bunn, 2016</a>].</li><li>A comprehensive assessment of medical and psychiatric history is needed to identify other causes for symptoms and to distinguish dementia from depression or delirium which often co-exist [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">GPAC, 2014</a>].</li></ul><h4>Assessing mental capacity and seeking informed consent</h4><ul><li>The British Medical Association (BMA) advises that explicit or implied patient consent is needed for all examinations, treatment or interventions, with the exceptions of emergency treatment, or when prescribed by law (for example compulsory treatment under mental health legislation) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMA, 2016a</a>].</li><li>Expert opinion in the NICE dementia guideline is that with the permission of the person with dementia, family/carers should be given an opportunity to be involved in care decisions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>].</li></ul><h4>Brief cognitive and mental state examination</h4><ul><li>Cognitive assessment is central to the diagnosis and management of dementia and should be performed in all people with suspected dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>].<ul><li>Screening tools cannot specifically identify the subtype of dementia, but they provide evidence that impairment exists and prompt a more formal evaluation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>]. </li><li>The use of a validated screening tool objectively measures cognitive abilities and changes in cognition during follow up [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>].</li></ul></li><li>The cognitive assessment tools listed are those described in the NICE dementia guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>].</li><li>The General Practitioner Assessment of Cognition (GPCOG) and 6-item Cognitive Impairment Test (6-CIT) have been found to be as clinically and psychometrically robust as the mini-mental state examination (MMSE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</li><li>A systematic review and meta-analysis of 149 studies including 11 different screening tests found that many tests other than the MMSE are comparable for detection of dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Tsoi, 2015</a>].</li></ul><h4>Assessing behavioural and psychological symptoms of dementia (BPSD)</h4><ul><li>More than 80% of people with Alzheimer's disease experience some behavioural symptoms such as anxiety, agitation, or depression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>].</li><li>BPSD (such as aggression, wandering, and getting lost) are associated with increased carer stress, depression, and lower quality of life [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Kales, 2015</a>].</li><li>Appropriate management of BPSD should start with an assessment in primary care to identify and treat any potential precipitants such as delirium, pain, diabetes, constipation, infection, sleep disturbance, other medical conditions (including anxiety and depression), medication (including the possibility of interactions and adverse effects). Be aware that uncontrolled pain can lead to distressed behaviour in people with dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">British Psychological Society, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE Pathway, 2016</a>].</li></ul><h4>Examining the person</h4><ul><li>Expert opinion in the EFNS guideline is that a neurological and general examination should be carried out in people with suspected dementia to identify co-morbidities and rule out alternative causes for symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>].</li></ul><h4>Arranging baseline investigations</h4><ul><li>Expert opinion in the EFNS guideline is that tests are useful in identification of alternative diagnoses, and potential risk factors. They are rarely useful in identification of the primary cause of dementia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Sorbi, 2012</a>].</li><li>A review article on dementia recommends that baseline investigations should be arranged before referral to secondary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</li></ul><!-- end field febd25f4-cc52-4731-b9ca-4501d14afe45 --><!-- end item ceb4cf57-77ca-4908-9006-1a08701f064e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}